Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
82.98 USD | -1.65% |
|
-3.16% | -21.20% |
06-24 | BioNTech, Duality Biologics Receive FDA Fast-Track Designation for Prostate Cancer Drug | MT |
06-24 | BioNTech Cancer Treatment Gets US FDA Fast Track Designation | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.20% | 20.36B | |
+16.38% | 122B | |
+21.33% | 116B | |
+22.18% | 27.03B | |
-16.89% | 16.43B | |
-18.01% | 15.91B | |
-44.74% | 15.6B | |
+61.20% | 14.94B | |
+3.35% | 13.59B | |
+122.77% | 11.24B |
- Stock Market
- Equities
- BNTX Stock
- News BioNTech SE
- US FDA Places Partial Clinical Hold on BioNTech's Cancer Drug Trial